Harrow (HROW) EPS (Weighted Average and Diluted) (2016 - 2026)
Harrow (HROW) recorded quarterly EPS (Weighted Average and Diluted) of -$0.74 in Q1 2026, down 511.11% quarter-over-quarter from $0.18 in Q4 2025, and down 48.0% on a YoY basis from -$1.42 in Q1 2025.
Harrow (HROW) EPS (Weighted Average and Diluted) (2016 - 2026) Analysis & Trends
Harrow's EPS (Weighted Average and Diluted) history runs 11 years deep, the most recent figure standing at -$0.74 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 48.0% year-over-year to -$0.74; the TTM figure through Mar 2026 stood at -$0.4 (up 34.43% YoY), while the FY2025 annual figure was -$0.14, up 71.43% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.74 for Q1 2026 at Harrow, down from $0.18 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.19 in Q4 2024 to a low of -$0.74 in Q1 2026.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.16 across 5 years, with a median of -$0.14 in 2023.
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) tumbled 1000.0% in 2022, then jumped 172.22% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.04 in 2022, then plunged by 775.0% to -$0.27 in 2023, then surged by 170.37% to $0.19 in 2024, then retreated by 5.26% to $0.18 in 2025, then slumped by 511.11% to -$0.74 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.74 (Q1 2026), $0.18 (Q4 2025), and $0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | -0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.74 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.38 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -0.09 |
| Sep 30, 2021 | -0.31 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.04 |